EXPIRED
MIDCAREER INVESTIGATOR AWARD IN MOUSE PATHOBIOLOGY RESEARCH Release Date: March 7, 2001 PA NUMBER: PAR-01-064 (This PAR has been reissued, see PAR-06-159) National Center for Research Resources National Institute on Aging PURPOSE This ongoing program Announcement (PAR) for the Midcareer Investigator Award in Mouse Pathobiology Research is being reissued. This PAR replaces PAR-99- 065 which was published February 19, 1999. The National Institutes of Health (NIH) is especially interested in increasing the number of scientists trained to conduct high-quality mouse pathobiology research. The purpose of the Midcareer Investigator Award in Mouse Pathobiology Research is to provide support for established outstanding pathobiologists to allow them protected time to devote to mouse pathobiology research, to relieve them from time consuming service obligations and administrative responsibilities, and to act as mentors for beginning investigators. The target candidates are scientists engaged in pathobiology research who are within 15 years of their specialty training, who can demonstrate the need for a period of intensive research focus as a means of enhancing their research careers, and who are committed to mentoring the next generation of mouse pathobiologists. This initiative is in response to recommendations established at the NIH meeting on "Priority Setting for Mouse Genomics and Genetics Resources," to increasing pressures created by the growing number of genetically altered mice being used by the biomedical research community, and to burgeoning opportunities for mouse pathobiologists in the biomedical research environment. The objectives of the Midcareer Investigator Award in Mouse Pathobiology Research are to encourage experienced, midcareer pathobiologists to: - devote more time to mouse pathobiology research by relieving these investigators from time-consuming institutional service, this protected time will advance their skills in conducting independent biomedical research. - increase their mentoring of beginning investigators in mouse pathobiology to build up the pool of skilled mouse pathologists who can fill the growing need for trained professionals to contribute in the exciting discoveries being made using genetically altered mice for biomedical research. - conduct state-of-the-art biomedical research in mouse pathobiology. This Award will enable candidates holding a Doctor of Veterinary Medicine or equivalent degree (see ELIGIBILITY REQUIREMENTS below) to undertake up to five years (a minimum of three years is required) of enhanced mouse pathobiology research, thereby further developing their research skills, devoting time to mouse pathobiology research, and acting as mentors and role models for beginning investigators. The prospective candidate for the Midcareer Investigator Award in Mouse Pathobiology Research should propose a period of research consistent with his/her research and/or clinical experience and with the proposed further development of his/her research skills. All programs should be carefully tailored to meet the individual needs of the candidate and must include a description of meritorious past research projects that meet the definition of mouse pathobiology research. In addition, the candidate should have a demonstrated record of mentoring and should describe mentoring activities that will involve pathobiology investigators with little or no research experience. Finally, at the time of application, the candidate should have a demonstrated record of significant, peer-reviewed research support in the field of mouse pathobiology. ELIGIBILITY REQUIREMENTS Most candidates for this award will have a Doctor of Veterinary Medicine degree (or equivalent) from an institution recognized by the American Veterinary Medical Association (AVMA). In addition, individuals holding other clinical (such as the M.D.) or research (such as the Ph.D.) degree(s) may apply for the award if they have been certified or have demonstrated the necessary expertise to perform high quality, funded research in mouse pathobiology. Candidates must have completed their specialty or research training within 15 years of submitting the application, and there is no age limit for candidates. In exceptional circumstances, the period of eligibility may be extended if it can be demonstrated that candidates had an interruption in their career progression due to family or personal circumstances. Candidates must be working in a research environment, conducting mouse pathobiology research, and have significant peer reviewed research support. This support can be as a principal or co-principal investigator, and needs to involve a significant project with biomedical relevance. Candidates must be willing to spend up to 50% effort (at least 25%) conducting mouse pathobiology research and mentoring. Candidates must describe a research and mentoring program that will meet their individual needs and capabilities. Applications may be submitted on behalf of candidates by domestic, non-Federal organizations, public or private, such as universities, veterinary, medical, dental, or nursing schools or other institutions of higher education. Minorities, women and individuals with disabilities are encouraged to apply. At the time of award, candidates must be citizens or noncitizen nationals of the United States, or must have been lawfully admitted to the United States for permanent residence (i.e., in possession of a currently valid Alien Registration Receipt Card I- 551, or other legal verification of such status). Noncitizen nationals are generally persons born in outlying possessions of the United States (i.e., American Samoa and Swains Island). Individuals on temporary visas are not eligible. A candidate for the MIDCAREER INVESTIGATOR AWARD IN MOUSE PATHOBIOLOGY RESEARCH may not concurrently apply for any other PHS award that duplicates the provisions of this award. Recipients of this award are required to hold independent research support, either Federal or private, during the period of this award. MECHANISM OF SUPPORT Awards in response to this program announcement will use the Midcareer Investigator Award in Biomedical and Behavioral Research (K26) mechanism. The purpose of the K26 award is to provide grant support for biomedical and behavioral scientists to allow them protected time to devote to their research and mentoring. Planning, direction, and execution of the program will be the responsibility of the candidate on behalf of the applicant institution. The project period may be for up to five years (at least three years are required). Awards are renewable for one additional five year period if the candidate still meets the stated requirements. The overall goal of the awarding Institute or Center (IC), i.e., the National Center for Research Resources (NCRR) or National Institute on Aging (NIA) is to support between four and six new awards in Fiscal Year 2001 and in each succeeding year through Fiscal Year 2004. The actual number of awards to be made will vary yearly and will be dependent upon the number and quality of applications submitted and funds available. RESEARCH OBJECTIVES A. Environment: The institution must have a well-established research and career development program. The institution must be able to demonstrate a commitment to the candidate as a productive, independent investigator. The candidate and institution must be able to describe a career program that will utilize the relevant research and educational resources, and the institution must certify that the candidate will be released from other duties and be able to devote up to 50 percent effort (at least 25 percent effort) to a mouse pathobiology research program. The institution must demonstrate the availability of beginning research-oriented investigators who will be mentored. B. Program: The award provides up to five consecutive 12-month awards. Up to 50 percent of the investigator"s effort (at least 25 percent) must be devoted to the mouse pathobiology research program and mentoring. The remainder may be devoted to other clinical, teaching, or research pursuits consonant with the objectives of the award. The research phase of an award period must be devoted to mouse pathobiology research in scientific areas relevant to the career goals of the candidate. C. Allowable Costs: 1. Salary: The NIH will provide salary and commensurate fringe benefits for the award recipient for up to 50 percent effort, up to the level of the current NIH extramural salary cap (in FY 2001, $161,200 per annum, or a maximum of $80,600 for 50 percent effort). At least 25 percent effort is required. The institution may supplement the NIH contribution up to a level that is consistent with the institution"s salary scale. Institutional supplementation of salary must not require extra duties or responsibilities that would interfere with the purpose of the award. The total salary requested must be based on a full-time, 12-month staff appointment. It must be consistent both with the established salary structure at the institution and with salaries actually provided by the institution from its own funds to other staff members of equivalent qualifications, rank, and responsibilities in the department concerned. If full-time, 12-month salaries are not currently paid to comparable staff members, the salary proposed must be appropriately related to the existing salary structure. 2. Research Development Support: The awarding IC (NCRR or NIA) will provide generally up to $25,000 per year for the following expenses: (a) research expenses, such as supplies, equipment and technical personnel for the principal investigator and his/her mentored investigators, (b) travel to research meetings or training, and c) statistical services including personnel and computer time. 3. Ancillary Personnel Support: Salary for secretarial and administrative assistance etc., is not allowed. 4. Facilities and Administrative costs: These costs will be reimbursed at 8 percent of modified total direct costs. D. Evaluation: In carrying out its stewardship of human resource related programs, the NIH may request information essential to an assessment of the effectiveness of this program. Accordingly, recipients are hereby notified that they may be contacted after the completion of this award for periodic updates on various aspects of their employment history, publications, support from research grants or contracts, honors and awards, professional activities, and other information helpful in evaluating the impact of the program. E. Special Leave: Leave to another institution, including a foreign laboratory, may be permitted if directly related to the purpose of the award. Only local, institutional approval is required if such leave does not exceed 3 months. For longer periods, prior written approval of the NIH funding component is required. To obtain prior approval, the award recipient must submit a letter to the awarding IC describing the plan, countersigned by his or her department head and the appropriate institutional official. A copy of a letter or other evidence from the institution where the leave is to be taken must be submitted to assure that satisfactory arrangements have been made. Support from the career award will continue during such leave. Leave without award support may not exceed 12 months. Such leave requires the prior written approval of the NIH funding component and will be granted only in unusual situations. Support from other sources is permissible during the period of leave. Such leave does not reduce the total number of months of program support for which an individual is eligible. Parental leave will be granted consistent with the policies of the NIH and the grantee institution. F. Termination or Change of Institution: When a grantee institution plans to terminate an award, the grants management staff at the awarding IC (NCRR or NIA) must be notified in writing at the earliest possible time so that appropriate instructions can be given for termination. If the individual is moving to another eligible institution, career award support may be continued provided: A new career award application is submitted by the new institution, All conditions of the award are met at the new institution, The period of support requested is no more than the time remaining within the existing award period, and The new application is submitted far enough in advance of the requested effective date to allow the necessary time for review by IC staff. The NIH may discontinue an award upon determination that the purpose or terms of the award are not being fulfilled. In the event an award is terminated, the Director of the NIH shall notify the grantee institution and career award recipient in writing of this determination, the reasons therefor, the effective date, and the right to appeal the decision. A final progress report, invention statement, and Financial Status Report are required upon either termination of an award or relinquishment of an award in a change of institution situation. APPLICATION PROCEDURES All candidates are strongly encouraged to contact the program staff listed under INQUIRIES. Such contact should occur early in the planning phase of application preparation. Such contact will help ensure that applications are responsive to the goals and policies of the participating IC. For applications relating to animal models, the IC contact would be the NCRR. For applications relating to aging, the IC contact would be the NIA. Applications are to be submitted on the grant application form PHS 398 (rev. 4/98), using the instructions in Section IV as appropriate) and will be accepted on or before the receipt dates indicated in the application kit. Forms are available at most institutional offices of sponsored research and from the Division of Extramural Outreach and Information Resources, National Institutes of Health, 6701 Rockledge Drive, MSC 7910, Bethesda, MD 20892-7910, Phone (301) 710-0267, FAX: (301) 480-0525, Email: [email protected]. Forms are also available on the NIH Website at http://grants.nih.gov/grants/forms.htm To identify the application as a response to this program announcement, check "YES" on item 2 of page 1 of the application and enter the number and title of this program announcement. Submit a signed, typewritten original of the application with five signed photocopies, in one package to: CENTER FOR SCIENTIFIC REVIEW NATIONAL INSTITUTES OF HEALTH 6701 ROCKLEDGE DRIVE, ROOM 1040 - MSC 7710 BETHESDA, MD 20892-7710 BETHESDA, MD 20817 (for express/courier service) The application must contain the following: Candidate o Evidence of the candidate"s ability to conduct high quality mouse pathobiology research. o A description of immediate and long-term career objectives, explaining how the award will contribute to their attainment. o A description of how the candidate will use the relief from institutional service or administrative duties to expand his or her expertise in mouse pathobiological research. o A description with evidence of the candidate"s commitment to a career in mouse pathobiology research. o This description of the candidate should not exceed six pages of the 25 page limit. One to two pages should be devoted to the candidate"s background (high quality mouse research), two to four pages to the candidate"s immediate and long-term career goals, and one to two pages to the candidate"s commitment to a career in mouse pathobiology research. Mentoring Plan o A demonstrated record of mentoring or training beginning investigators (e.g., graduate students, residents, post-doctoral fellows, visiting scientists) or a demonstration of the capability to provide mentoring to beginning investigators. o A description of plans for providing mentoring opportunities to beginning investigators, including a description of the types of investigators that could be mentored, plans for recruiting and selecting such individuals, and the training and educational experiences to be provided. Research Plan o A commitment of up to 50 percent effort (at least 25 percent effort) to the mouse pathobiology research program. o A description of ongoing mouse pathobiology research. The research plan should briefly describe the specific aims, background and significance, and the research design and methods of the study. Emphasis should be given to the initial three years of the award. o This description of the research plan should not exceed 20 pages of the 25 page limit that includes the description of the candidate. One to two pages should be devoted to state the hypothesis and specific aims, two to four pages should state the background, significance, and rationale, and two to four pages should summarize previous studies and their results. o Documentation that appropriate and adequate resources, both in terms of support and facilities, are available to the candidate, to conduct the research program. This must include a description of other monetary support that will be utilized to conduct the research program. Environment and Institutional Commitment o The sponsoring institution must document a strong, well-established mouse pathobiology research and training program related to the candidate"s area of interest including a high-quality research environment with staff capable of productive collaboration with the candidate. The sponsoring institution also must provide a statement of commitment to enhancing the candidate"s ability as a productive, independent investigator. o The sponsoring institution must provide documentation that the candidate will be relieved from other duties, i.e. animal care, facility management, administrative, etc., to allow him/her to devote time to the mouse pathobiology research program. Budget Instructions The total direct costs must be requested in accordance with the K26 program guidelines, following the budget instructions described in the Career Award Section of the PHS 398 (rev. 4/98). Biographical Sketch A biographical sketch is required for all key personnel, following the instructions in the career award section of the PHS 398 (rev. 4/98). REVIEW CONSIDERATIONS Applications will be reviewed for completeness by the Center for Scientific Review and for responsiveness to this program announcement by the awarding IC staff. Incomplete and/or non-responsive applications will be returned to the applicant without further consideration. Applications that are complete and responsive to the program announcement will be evaluated for scientific and technical merit by a peer review group convened by the awarding IC in accordance with the standard NIH peer review procedures. As part of the initial merit review, all applications will receive a written critique and undergo a process in which only those applications deemed to have the highest scientific merit, generally the top half of applications under review, will be discussed, assigned a priority score, and receive a second level review by the National Advisory Research Resources Council (NARRC) or the National Advisory Council on Aging (NACA). The following review criteria will be applied: Candidate o Quality of the candidate"s academic and professional record, including capabilities and commitment to serve as a mentor, o Evidence of ongoing high quality mouse pathobiology research and the relationship of that research to this program, o Potential to conduct quality mouse pathobiology research, o Commitment to a mouse pathobiology research career, o Appropriateness of the content and duration of the proposed research program, o Evidence of monetary support for the proposed research. Mentoring Plan o Experience serving as a mentor, this mentoring may include graduate students, residents, junior professionals, or visiting scientists who seek training in mouse pathobiology. o Adequacy of the plans for mentoring or supervising beginning investigators in mouse pathobiology, plans for the potential development and expansion of the training plan. Research Plan Although it is understood that the K26 application does not require the level of detail necessary in other research grant applications, a fundamentally sound research plan must be provided for award years one through three. In general, less detail is expected of the planned research for years four and five (if appropriate), but the application should outline the general goals for those years. o Appropriateness of the research plan to capitalize on the growing opportunities of available mouse pathobiology resources and to expand technical skills, o Scientific and technical merits of the proposed research, o Relevance of the proposed research to the candidate"s career objectives, o Availability of adequate resources to conduct the proposed research, o Demonstration that the proposed program will relieve the candidate from other service or administrative duties and allow him/her to devote time to mouse pathobiology research. Environment and Institutional Commitment o Applicant institution"s commitment to the scientific development of the candidate and assurances that the institution intends the candidate to be an integral part of its research program, o Adequacy of research facilities and the availability of appropriate educational opportunities, o Quality and relevance of the environment for scientific and professional development of the candidate and others pursuing mouse pathobiology research, and o Applicant institution"s commitment to provide adequate time for conduct of the research program. AWARD CRITERIA The institute or center will notify the applicant of the appropriate Council"s action shortly after its meeting. Funding decisions will be made based on the recommendations of the initial review group, NARRC or NACA, the need for research personnel in specific program areas, and the availability of funds. The NIH policy on submission of revised (amended) applications limits the number of such applications to two. INQUIRIES Written and telephone inquiries concerning this program announcement are strongly encouraged especially during the planning phase of the application. Direct inquiries regarding programmatic issues to: Franziska Grieder, D.V.M., Ph.D. Comparative Medicine area National Center for Research Resources 6705 Rockledge Drive, Room 6050 Bethesda, MD 20892-7965 Telephone: (301) 435-0744 FAX: (301) 480-3819 Email: [email protected] Directed inquiries regarding research and training related to age-related pathology to: Huber R. Warner, Ph.D. Biology of Aging Program National Institute on Aging Gateway Building, Room 2C231 Bethesda, MD 20892 Telephone: (301) 496-6402 FAX: (301) 402-0010 Email: [email protected] Direct inquiries regarding fiscal matters to: Ms. Irene Grissom Office of Grants Management National Center for Research Resources 6705 Rockledge Drive, Room 6086 Bethesda, MD 20892-7965 Telephone: (301) 435-0844 FAX: (301) 480-3777 Email: [email protected] Linda Whipp Grants and Contracts Management Office National Institute on Aging 7201 Wisconsin Avenue, Gateway Building, Suite 2N212 Bethesda, MD 20892 Telephone: (301) 496-1472 FAX: (301) 402-3672 Email: [email protected] URLS IN NIH GRANT APPLICATIONS OR APPENDICES All applications and proposals for NIH funding must be self-contained within specified page limitations. Unless otherwise specified in an NIH solicitation, Internet addresses (URLs) should not be used to provide information necessary to the review because reviewers are under no obligation to view the Internet sites. Reviewers are cautioned that their anonymity may be comprised when they directly access an Internet site. HEALTHY PEOPLE 2010 The Public Health Service (PHS) is committed to achieving the health promotion and disease prevention objectives of "Healthy People 2010," a PHS-led national activity for setting priority areas. This PAR, Midcareer Investigator Award in Mouse Pathobiology Research, is related to one or more of the priority areas. Potential candidates may obtain a copy of "Healthy People 2010" from the Superintendent of Documents, Government Printing Office, Washington, DC 20402-9325 (telephone 202/512-1800) or electronically (http://www.health.gov/healthypeople). AUTHORITY AND REGULATIONS This program is described in the Catalog of Federal Domestic Assistance Nos. 93.855 and 93.856. Awards are made under the authority of title III, Section 301 of the PHS Act as amended. The Code of Federal Regulations, Title 42 Part 52 and Title 45 Part 74, are applicable to this program. This program is not subject to the intergovernmental review requirements of Executive Order 12372 to Health Systems Agency review. The PHS strongly encourages all grant and contract recipients to provide a smoke-free workplace and promote the non-use of all tobacco products. In addition, Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking in certain facilities (or in some cases, and portion of a facility) in which regular or routine education, library, day care, health care or early childhood development services are provided to children. This is consistent with the PHS mission to protect and advance the physical and mental health of the American people.
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
| ||||||
Department of Health and Human Services (HHS) |
||||||
NIH... Turning Discovery Into Health® |